ALAMEDA, Calif.--(BUSINESS WIRE)--Celera (NYSE:CRA), an Applera Corporation business, today announced it has completed the acquisition of Berkeley HeartLab, Inc. (BHL), for approximately $195 million in cash. BHL is a cardiovascular healthcare company with a broad portfolio of CLIA certified tests and disease management services focused on the secondary prevention market. BHL has approximately 300 employees including 110 laboratory personnel and about 80 field-based sales representatives and clinical educators, and will be operated as a business unit of Celera.
